恒瑞医药：公司注射用甲苯磺酸瑞马唑仑的药品上市许可申请获国家药监局受理

Core Viewpoint - Heng Rui Medicine's application for the market approval of its injectable remimazolam tosylate has been accepted by the National Medical Products Administration, targeting sedation during mechanical ventilation in intensive care [1] Group 1 - The drug is intended for use in sedation during mechanical ventilation in intensive care settings [1]